Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported Operating Income of -$12.12 million for fiscal year 2025.
ASSEMBLY BIOSCIENCES, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$12.12M | +73.3% |
| 2024 | -$45.42M | +29.7% |
| 2023 | -$64.65M | +31.3% |
| 2022 | -$94.11M | +29.1% |
| 2021 | -$132.69M | -104.8% |
| 2020 | -$64.78M | +36.9% |
| 2019 | -$102.71M | -10.8% |
| 2018 | -$92.73M | -77.6% |
| 2017 | -$52.23M | -15.3% |
| 2016 | -$45.28M | -52.7% |
| 2015 | -$29.66M | -23.8% |
| 2014 | -$23.96M | -22.2% |
| 2013 | -$19.60M | +21.1% |
| 2012 | -$24.86M | +26.9% |
| 2011 | -$34.00M | -613.4% |
| 2010 | -$4.77M | -42.7% |
| 2009 | -$3.34M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$10.88M | +0.7% | +1.9% |
| June 30, 2025 | -$11.09M | +9.1% | -11.6% |
| March 31, 2025 | -$9.94M | +7.3% | +9.3% |
| September 30, 2024 | -$10.96M | +27.2% | +10.2% |
| June 30, 2024 | -$12.20M | +30.2% | -13.7% |
| March 31, 2024 | -$10.73M | +45.1% | +28.7% |
| September 30, 2023 | -$15.05M | +35.7% | +14.0% |
| June 30, 2023 | -$17.49M | +28.8% | +10.6% |
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +73.3% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, ASSEMBLY BIOSCIENCES, INC.’s operating income has declined by 262.8% (from -$3.34 million to -$12.12 million).
- The most recent figure is from ASSEMBLY BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: